Neurotoxicity of Panipenem/Betamipron, a New Carbapenem, in Rabbits : Correlation to Concentration in Central Nervous System
スポンサーリンク
概要
- 論文の詳細を見る
The neurotoxic potential of panipenem/betamipron (PAPM/BP), a new carbapenem antibiotic, was compared with that of imipenem/cilastatin (IPM/CS). The drug concentration in cerebrospinal fluid (CSF) at the onset of epileptogenic electroencephalographic (EEG)-activity and the drug distribution into the central nervous system (CNS) were evaluated. Epileptogenic reactions correlated well with drug levels in CSF, but not with drug levels in circulating plasma. The concentration of PAPM in CSF at the onset of epileptogenic EEG-activity was almost twice that of IPM, suggesting that neurotoxic activity of PAPM is about half that of IPM. In addition, in terms of incidence percent for the epileptogenic EEG-activity, PAPM/BP was found to be less toxic than IPM/CS within the dose of 1.0-1.2 g/kg. Concentrations of PAPM in CSF and brain extracellular fluid after PAPM/BP i.v. infusion were comparable with those of IPM after IPM/CS infusion, indicating the similar characteristics of distribution into the CNS for the two antibiotics. From these results of pharmacologic effects and drug distributions, it is suggested that the neurotoxicity of PAPM/BP is less than half that of IPM/CS.
- 公益社団法人日本薬学会の論文
著者
-
Kurihara Atsushi
Product Development Laboratories Sankyo Co. Ltd.:institute Of Science Technology Inc.
-
Mikuni Naoji
Product Development Laboratories Sankyo Co. Ltd.:institute Of Science Technology Inc.
-
HISAOKA Masafumi
Product Development Laboratories, Sankyo Co., Ltd.
-
KAMOSHIDA Katsuo
Product Development Laboratories, Sankyo Co., Ltd.
-
Kamoshida Katsuo
Product Development Laboratories Sankyo Co. Ltd.:institute Of Science Technology Inc.
-
Hisaoka Masafumi
Product Development Laboratories Sankyo Company Ltd.
関連論文
- Neurotoxicity of Panipenem/Betamipron, a New Carbapenem, in Rabbits : Correlation to Concentration in Central Nervous System
- STUDIES ON LIPOSOME-ENCAPSULATED CARBOQUONE. IV. ENHANCEMENT OF ANTITUMOR ACTIVITY OF CARBOQUONE AGAINST EHRLICH ASCITES CARCINOMA BY ENCAPSULATION
- STUDIES ON LIPOSOME-ENCAPSULATED CARBOQUONE. III. ENHANCEMENT OF LYMPHATIC TRANSPORT OF CARBOQUONE BY ENCAPSULATION
- STUDIES ON LIPOSOME-ENCAPSULATED CARBOQUONE. II. EFFECT OF LIPOSOMAL ENCAPSULATION OF CARBOQUONE ON DISTRIBUTION AND CLEARANCE IN ANIMALS
- Effects of ranitidine, metoclopromide, and anisotropine methylbromide on the availability of cefpodoxime proxetil (CS-807) in Japanese Healthy subjects.